Vivos (RDGL) Cash from Operations (QoQ) (2010 - 2025)
Vivos (RDGL) Cash from Operations (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn |
| 10 | Vivos | 27.62 Mn | 26.06 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.68% |
| Sep 30, 2025 | 24.16% |
| Jun 30, 2025 | -32.80% |
| Mar 31, 2025 | 3.34% |
| Dec 31, 2024 | 6.98% |
| Sep 30, 2024 | -42.44% |
| Jun 30, 2024 | -1.13% |
| Mar 31, 2024 | 24.11% |
| Dec 31, 2023 | -108.69% |
| Sep 30, 2023 | 29.40% |
| Jun 30, 2023 | -7.05% |
| Mar 31, 2023 | -4.25% |
| Dec 31, 2022 | 0.46% |
| Sep 30, 2022 | -65.37% |
| Jun 30, 2022 | 55.47% |
| Mar 31, 2022 | -63.21% |
| Dec 31, 2021 | -32.23% |
| Sep 30, 2021 | 48.71% |
| Jun 30, 2021 | -70.94% |
| Mar 31, 2021 | 44.45% |